PRME ▲ +10.2% - Prime Medicine, Inc. $PRME Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency 24-SEP-2026 04:04 PM ET